Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Other financing activities (2020 - 2025)

Historic Other financing activities for GoHealth (GOCO) over the last 5 years, with Q3 2025 value amounting to $8.0 million.

  • GoHealth's Other financing activities rose 7617.05% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 12382.95%. This contributed to the annual value of $1.6 million for FY2022, which is 6005.36% down from last year.
  • Per GoHealth's latest filing, its Other financing activities stood at $8.0 million for Q3 2025, which was up 7617.05% from -$13.6 million recorded in Q4 2024.
  • GoHealth's Other financing activities' 5-year high stood at $8.0 million during Q3 2025, with a 5-year trough of -$13.6 million in Q4 2024.
  • In the last 4 years, GoHealth's Other financing activities had a median value of $1.7 million in 2021 and averaged $583750.0.
  • Its Other financing activities has fluctuated over the past 5 years, first soared by 47841.73% in 2021, then tumbled by 14488.0% in 2022.
  • Quarter analysis of 4 years shows GoHealth's Other financing activities stood at $2.5 million in 2021, then plummeted by 144.88% to -$1.1 million in 2022, then tumbled by 1110.7% to -$13.6 million in 2024, then surged by 158.72% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, -$13.6 million for Q4 2024, and $4.5 million during Q3 2024.